Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 24, 268-279, February 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kyogoku, M.
Right arrow Articles by Pressman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kyogoku, M.
Right arrow Articles by Pressman, D.

Localizing Properties of Anti-Rat Hepatoma Antibodies in Vivo*

Masahisa Kyogoku{dagger}, Yasuo Yagi, Jakob Planinsek, Joseph Bernecky and David Pressman

( Department of Biochemistry Research, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York)

The localizing properties of the antibodies against the stroma sediments of N-2-fluorenylacetamide-induced hepatoma and normal liver were compared in tumor and normal rats. Radioautography with I125-labeled antibodies and the fluorescent antibody technic were used.

When the globulin fractions of both antisera were injected directly into the tumor-bearing rat as well as the normal rat, antibody localized on the walls of sinusoids and in connective tissue parts of tumor as well as in normal liver. No difference has been found between the localization properties of both sera.

However, after passage through normal rat there were some differences in the localization pattern of these two antisera in the tumor. The anti-hepatoma antibody still localized specifically in the dense connective tissue, but no such preferential localization was observed with the anti-normal liver serum. There was no specific localization on the wall of sinusoid-like vascular channels with either serum, a condition clearly observed when the original globulin was used.

The possible reason for this difference was discussed, and the usefulness of the combination of I125-radioautography and fluorescent antibody technic for the detection of the site of localization of antibody at a cellular level is stressed.

* Supported in part by the American Cancer Society, Grant T-242, and the Atomic Energy Commission, Contract AT(30-1) 2651.

{dagger} Fulbright Research Scholar on leave of absence from the Department of Pathology, Kyoto University Medical School, Kyoto, Japan.

Received 8/ 2/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1964 by the American Association for Cancer Research.